Zantac Heartburn Medication Recalled After Cancer Risk Scare
Pharmaceutical manufacturer GlaxoSmithKline (GSK) is recalling the popular heartburn drug Zantac in all markets as a “precaution,” just days after the Food and Drug Administration (FDA) found “unacceptable” levels of a probable cancer-causing impurity known as N-Nitrosodimethylamine (NDMA). Zantac May Contain High Levels of NDMA On October 8, 2019, GSK said it was recalling four>> Read More